文献速递皮肤肿瘤银屑病与炎症性皮肤病

表皮TLR4基因缺失可保护SKH-1小鼠免受急性和致瘤性紫外线损伤

TLR4 epidermal genetic deletion protects against acute and tumorigenic UV exposure in SKH-1 mouse skin.
PubMed 文献 · J Invest Dermatol · 2026-10-01

该研究在SKH-1小鼠中比较表皮角质形成细胞特异性Tlr4敲除与全身系统性敲除对紫外线反应的影响。结果显示表皮Tlr4敲除小鼠可抵抗UV诱导的急性光损伤和慢性光致癌,其保护效应模拟了局部拮抗剂resatorvid的作用,而系统性敲除未见此效果,提示表皮TLR4是皮肤癌光化学预防的潜力靶点。

要点

  • 表皮角质形成细胞特异性Tlr4敲除可抵抗UV诱导的急性光损伤。
  • 表皮Tlr4敲除可抵抗慢性UV诱导的光致癌作用。
  • 表皮TLR4是皮肤癌光化学预防的潜力靶点。

核心结论

  • 表皮角质形成细胞中的TLR4是UV诱导炎症信号和光致癌的关键调控点。
  • 表皮Tlr4敲除的保护效应与局部药理学拮抗(resatorvid)一致,而系统性Tlr4敲除未见此保护效应。

研究设计与样本

  • 研究在SKH-1小鼠中生成转基因模型,比较表皮角质形成细胞限制性Tlr4敲除与全身系统性Tlr4敲除状态。
  • 采用转录组学、蛋白质组学分析及免疫 profiling 评估UV诱导的反应。

主要发现

  • 表皮Tlr4敲除小鼠对UV诱导的急性光损伤具有保护作用。
  • 表皮Tlr4敲除小鼠对慢性UV诱导的光致癌具有保护作用。
  • 表皮Tlr4敲除的光保护效应模拟了局部应用resatorvid(TAK-242)的效果。
  • 携带系统性Tlr4缺失的转基因小鼠未观察到上述保护效应。

临床怎么用

  • 结果支持将表皮TLR4作为皮肤癌光化学预防的候选靶点进行进一步研究。
  • 局部药理学拮抗TLR4(如resatorvid)在动物模型中显示出光保护潜力。

局限性

  • 研究仅在SKH-1小鼠模型中进行,尚未在人体中验证。
  • 原文未报告具体的样本量、效应量、P值或置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epidermal keratinocytes play a key role in regulating skin immune responses. However, their specific involvement in inflammatory signaling triggered by solar ultraviolet (UV) radiation, which contributes to the development of cutaneous squamous cell carcinoma, is not yet fully understood. It is now known that environmental UV exposure activates Toll-Like Receptor 4 (TLR4), initiating inflammatory signaling pathways. Given the emerging evidence linking TLR4 to UV-induced skin damage, we recently tested the TLR4 antagonist resatorvid (TAK-242) in SKH-1 mouse models. Our findings show that topical application of resatorvid significantly reduces UV-induced inflammatory signaling and lowers the incidence of skin cancer in these models. We have now generated transgenic mice allowing comparison between Tlr4 knockout confined to epidermal keratinocytes versus total systemic knockout status to examine its role in the modulation of solar UV-induced responses. Using transcriptomic and proteomic analysis, together with immune profiling, we observed that epidermal Tlr4 knockout mice are protected against UV-induced acute photodamage and chronic UV-induced photocarcinogenesis. Strikingly, epidermal KO status mimics the photoprotective impact of pharmacological antagonism (topical resatorvid), an effect not observed in transgenic mice harboring systemic deletion of Tlr4. Taken together, these findings demonstrate that epidermal TLR4 represents a promising target for skin cancer photochemoprevention.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Dickinson SE, Jandova J, Vaishampayan P, et al. TLR4 epidermal genetic deletion protects against acute and tumorigenic UV exposure in SKH-1 mouse skin. J Invest Dermatol. 2026. PMID: 42822662. doi:10.1016/j.jid.2026.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。